Compositions for use in treating or diagnosing bone disorders and/or cardiovascular disorders

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9212362
APP PUB NO 20150119450A1
SERIAL NO

14561585

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Compositions of an inhibitor of a polynucleotide for use in treating or preventing bone disorders such as osteoporosis, osteopenia, bone fracture, bone cancer, as well as impaired bone homeostasis. Preferred compounds to be used in these medical interventions are antagonistic compounds, like nucleic acid molecules, directed against miR-31 and derivatives thereof. Also, methods for diagnosing and compositions for use in diagnosing bone disorders. Compounds to be employed in these diagnostic methods and uses include compounds such as miR-31.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
UNIVERSITAT FUR BODENKULTUR WIENGREGOR-MENDEL-STRASSE 33 WIEN 1180

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Fortschegger, Klaus Vienna, AT 4 3
Grillari, Johannes Bisamberg, AT 13 15
Grillari, Regina Bisamberg, AT 8 15
Schraml, Elisabeth Vienna, AT 5 5

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 15, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00